+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market - Global Forecast 2025-2030- Product Image
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market - Global Forecast 2025-2030- Product Image
Sale

Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6136957
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Ultrasound-guided non-invasive liver fibrosis diagnostics are advancing clinical workflows and reshaping chronic liver disease management through innovative imaging modalities. Senior decision-makers across healthcare and technology sectors are leveraging these tools to improve patient outcomes and streamline diagnostic pathways.

Market Snapshot: Ultrasound-Guided Non-Invasive Liver Fibrosis Diagnostics

The market for ultrasound-guided non-invasive diagnostics is experiencing substantial growth, driven by improved imaging technologies and shifting clinical priorities. Innovations such as shear wave elastography and transient elastography are enabling more accurate, patient-friendly liver fibrosis assessments at the point of care. Enhanced portability, operational integration, and clinician acceptance are supporting widespread adoption. As market competition intensifies, manufacturers and providers increasingly focus on solutions that balance performance, cost-effectiveness, and adaptability across care environments.

Scope & Segmentation

This report provides detailed analysis by examining all key sub-segments and regional trends shaping the ultrasound-guided non-invasive diagnostics sector. The research addresses:

  • Technology Types: Acoustic Radiation Force Impulse, Shear Wave Elastography (Point, Two Dimensional), Transient Elastography (Benchtop, Portable)
  • End Users: Ambulatory Care Centers, Diagnostic Centers, Hospitals (Primary, Tertiary), Research Institutes
  • Applications: Diagnosis (Fibrosis Staging, Initial Diagnosis), Monitoring (Disease Progression, Treatment Monitoring), Research, Screening (General Population, High Risk)
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, South Africa, and more), Asia-Pacific (featuring China, India, Japan, Australia, South Korea, among others)
  • Company Developments: Profiles and trend analysis for Echosens S.A.S., GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Samsung Medison Co., Ltd., Mindray Medical International Limited, Fujifilm SonoSite, Inc., Hitachi, Ltd., Hologic, Inc.

Key Takeaways

  • Non-invasive ultrasound technologies such as shear wave and transient elastography are reducing clinical reliance on invasive biopsy, supporting broader adoption among clinicians and patients.
  • Healthcare providers value diagnostic systems that integrate with electronic health records and offer standardized measurement protocols to enhance workflow efficiency and disease monitoring accuracy.
  • Strategic partnerships—between device manufacturers, software companies, and pharmaceutical firms—are accelerating development of AI-driven analytics, deepening the value proposition of ultrasound-guided platforms.
  • Regional nuances—from payer landscapes in the Americas to government initiatives in Asia-Pacific—are determining pace and scale of adoption, highlighting the importance of tailored go-to-market strategies.
  • End-user segmentation signals a shift toward portable, user-friendly equipment designed for both high-throughput environments and decentralized community care.
  • In the competitive landscape, differentiated product tiers address both premium performance requirements and affordability for emerging markets.

Tariff Impact

Recent United States tariff policies have introduced new cost pressures in the supply chain for ultrasound-guided diagnostic equipment. Increased duties on key components have elevated acquisition costs for manufacturers, with downstream effects on providers planning equipment upgrades. In response, market participants are renegotiating supply terms, increasing localized assembly, and diversifying sourcing to minimize price volatility and lead times. Continued collaboration with trade authorities remains essential to maintain affordability and patient access for key diagnostic modalities.

Methodology & Data Sources

This research integrates secondary data—including peer-reviewed journals, clinical registries, and regulatory filings—with primary interviews from clinicians, engineers, manufacturers, and industry experts. Insights are validated through triangulation across proprietary industry databases, patent filings, and expert panels, ensuring analytical rigor and actionable intelligence.

Why This Report Matters

  • Enables strategic decision-making by presenting in-depth segmentation, technology trends, and regional drivers relevant to ultrasound-guided non-invasive liver fibrosis diagnostics.
  • Identifies actionable opportunities for optimizing product portfolios, training, and market entry, tailored for senior executives, innovators, and investors.
  • Aligns business strategies with evolving clinical priorities and regulatory frameworks, supporting sustainable growth and competitive differentiation.

Conclusion

Senior leaders in healthcare technology can leverage this report to inform investments, drive partnership development, and anticipate key challenges in the evolving landscape of ultrasound-guided non-invasive liver fibrosis diagnostics. Proactive strategies based on these insights will strengthen competitive positioning and patient care delivery.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of point-of-care shear wave elastography for early fibrosis detection in outpatient clinics
5.2. Integration of artificial intelligence algorithms with transient elastography systems to enhance diagnostic accuracy
5.3. Expansion of telemedicine-compatible ultrasound platforms enabling remote liver stiffness assessment in underserved regions
5.4. Development of contrast-enhanced ultrasound techniques for improved visualization of early fibrotic changes in liver tissue
5.5. Increasing investment in portable handheld ultrasound devices for rapid on-site liver fibrosis screening at point of care
5.6. Regulatory approvals of new standardized scoring software for consistent quantification of liver fibrosis using ultrasound data
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market, by Technology Type
8.1. Introduction
8.2. Acoustic Radiation Force Impulse
8.3. Shear Wave Elastography
8.3.1. Point
8.3.2. Two Dimensional
8.4. Transient Elastography
8.4.1. Benchtop
8.4.2. Portable
9. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Diagnostic Centers
9.4. Hospitals
9.4.1. Primary
9.4.2. Tertiary
9.5. Research Institutes
10. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market, by Application
10.1. Introduction
10.2. Diagnosis
10.2.1. Fibrosis Staging
10.2.2. Initial Diagnosis
10.3. Monitoring
10.3.1. Disease Progression
10.3.2. Treatment Monitoring
10.4. Research
10.5. Screening
10.5.1. General Population
10.5.2. High Risk
11. Americas Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Echosens S.A.S.
14.3.2. GE HealthCare Technologies Inc.
14.3.3. Siemens Healthineers AG
14.3.4. Koninklijke Philips N.V.
14.3.5. Canon Medical Systems Corporation
14.3.6. Samsung Medison Co., Ltd.
14.3.7. Mindray Medical International Limited
14.3.8. Fujifilm SonoSite, Inc.
14.3.9. Hitachi, Ltd.
14.3.10. Hologic, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET: RESEARCHAI
FIGURE 22. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET: RESEARCHSTATISTICS
FIGURE 23. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET: RESEARCHCONTACTS
FIGURE 24. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY ACOUSTIC RADIATION FORCE IMPULSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY ACOUSTIC RADIATION FORCE IMPULSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY POINT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY POINT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TWO DIMENSIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TWO DIMENSIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY BENCHTOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY PORTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY PRIMARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TERTIARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TERTIARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY FIBROSIS STAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY FIBROSIS STAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY INITIAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY INITIAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DISEASE PROGRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DISEASE PROGRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY GENERAL POPULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY GENERAL POPULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HIGH RISK, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HIGH RISK, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 116. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 117. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 118. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 119. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 126. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 127. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 128. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 129. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 130. CANADA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 226. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2018-2024 (USD MILLION)
TABLE 228. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY TRANSIENT ELASTOGRAPHY, 2025-2030 (USD MILLION)
TABLE 229. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 238. GERMANY ULTRASOUND-GUIDED NON-INVASIVE DIAGNOSTIC OF LIVER FIBROSIS MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 239. GERMANY ULTRASOUND-GUID

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market report include:
  • Echosens S.A.S.
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Samsung Medison Co., Ltd.
  • Mindray Medical International Limited
  • Fujifilm SonoSite, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.

Related Topics

Related Reports

Medical Ultrasound Elastography Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Medical Ultrasound Elastography Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Liver Disease Diagnostics Market Report 2025 - Product Image

Liver Disease Diagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Liver Ultrasound Imaging System Market - Global Forecast 2025-2030 - Product Image

Liver Ultrasound Imaging System Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Liver Fibrosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Liver Fibrosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Liver Fibrosis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 - Product Image

Liver Fibrosis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.